November 29, 2021
2 mins read

WHO still unclear over ‘Omicron’

WHO confirmed that there is currently no information to suggest that symptoms associated with Omicron are different from those from other variants…reports Asian Lite News

 It is not yet clear whether the Omicron Covid-19 variant is more transmissible, or causes more severe disease compared to other variants, including Delta, the World Health Organization (WHO) has said.

It’s not yet clear whether Omicron is more easily spread from person to person compared to other variants, even though the number of people testing positive has risen in South Africa where this variant was involved, the WHO on Sunday added.

It’s also not yet clear whether Omicron causes more severe disease, but preliminary data suggests that there are increasing rates of hospitalisation in South Africa, which however may be due to increasing overall number of people becoming infected, Xinhua news agency reported.

WHO confirmed that there is currently no information to suggest that symptoms associated with Omicron are different from those from other variants, as understanding the level of severity of the Omicron variant will take days to several weeks.

All variants of Covid-19, including the Delta variant that is currently dominant worldwide, can cause severe disease or death, in particular for the most vulnerable people, and thus prevention is always key.

ALSO READ: Global Covid caseload tops 261.46 mn

However, WHO said preliminary evidence suggests there may be an increased risk of reinfection with Omicron but information is limited. More information on this will become available in the coming days and weeks.

It added that current PCR tests continue to detect Omicron while further studies are still going on to understand how the Omicron variant will impact on available vaccines and treatments to Covid-19.

WHO classified on Friday the latest variant B.1.1.529 of SARS-CoV-2 virus, now with the name Omicron, as a “Variant of Concern” (VOC).

According to WHO’s definition, a VOC, with a degree of global public health significance demonstrates one or more of mutational changes such as increase in transmissibility or detrimental change in Covid-19 epidemiology, increase in virulence or change in clinical disease presentation, and decrease in effectiveness of public health and social measures or available diagnostics, vaccines and therapeutics.

WHO has since urged countries to enhance surveillance and sequencing on circulating SARS-CoV-2 variants, submit complete genome sequences and metadata to a publicly available database, and report initial VOC cases or clusters to WHO.

It has also recommended field investigations and laboratory assessments to better understand potential impacts of the VOC on Covid-19 epidemiology, the effectiveness of public health and social measures and antibody neutralisation.

ALSO READ: New Covid rules from Tuesday

Previous Story

New Zealand tourism releases recovery plan

Next Story

Omicron: Nepal bans African travellers

Previous Story

New Zealand tourism releases recovery plan

Next Story

Omicron: Nepal bans African travellers

Latest from -Top News

EU Faces Calls to Act on Bangladesh Rights Violations

Bangladesh’s political transition has done little to silence concerns over the country’s human rights record…writes Dr Sakariya Kareem More than two years after the student-led uprising that ended Sheikh Hasina’s rule in

ASEAN kicks off Manila summit with global ambitions

ASEAN leaders gather in Manila for a three-day summit focused on energy security, food supplies and economic cooperation…reports Asian Lite News Desk The 49th Association of Southeast Asian Nations (ASEAN) Summit and
Go toTop

Don't Miss

‘We’re prepared for future emergencies’ says UAE as Covid cases pass 1m

Sheikh Sultan pointed to the creation of the Frontline Heroes

No evidence Omicron has lower severity than Delta variant

The yet-to-be-published study used data for all PCR-confirmed SARS-CoV-2 cases